Stacey Melquist
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
-
- Lipid metabolism and disorders
Papers in ⓘ
-
- Cancer, Lipids, and Metabolism 9
-
- Lipid metabolism and disorders 12
- Co-authors
- Judith Bender (3 shared papers)Ashley Cannon (4 shared papers)Michael Hutton (3 shared papers)Linda R. White (4 shared papers)Sigrid Botne Sando (4 shared papers)Jan Aasly (4 shared papers)Stian Lydersen (2 shared papers)Ingvild Saltvedt (2 shared papers)
- Journals
- Circulation (6 papers)Journal of clinical lipidology (4 papers)Nature Medicine (2 papers)Neurology (2 papers)Genetics (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Stacey Melquist
29 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Neurology 107
- Cardiology and Cardiovascular Medicine 289
- Cancer Research 176
- Endocrinology, Diabetes and Metabolism 194
- Physiology 280
Countries citing papers authored by Stacey Melquist
This map shows the geographic impact of Stacey Melquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Melquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Melquist more than expected).
Fields of papers citing papers by Stacey Melquist
This network shows the impact of papers produced by Stacey Melquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Melquist. The network helps show where Stacey Melquist may publish in the future.
Co-authors
The 25 scholars most cited alongside Stacey Melquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 194 | |
| 2 | Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) Hit paper breakdown → | 2022 | 167 |
| 3 | 2014 | 138 | |
| 4 | Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia Hit paper breakdown → | 2024 | 103 |
| 5 | 2006 | 79 | |
| 6 | 1999 | 79 | |
| 7 | 2003 | 78 | |
| 8 | 2023 | 65 | |
| 9 | 2008 | 62 | |
| 10 | 2007 | 45 | |
| 11 | 2023 | 41 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 31 | |
| 14 | 2006 | 28 | |
| 15 | 2005 | 25 | |
| 16 | 2004 | 23 | |
| 17 | 2021 | 17 | |
| 18 | RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects | 2019 | 15 |
| 19 | 2020 | 14 | |
| 20 | 2020 | 13 |
About Stacey Melquist
Stacey Melquist is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Biological Psychiatry, Surgery and Psychiatry and Mental health, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lipid metabolism and disorders (12 papers), Cancer, Lipids, and Metabolism (9 papers), Lipoproteins and Cardiovascular Health (7 papers), Alzheimer's disease research and treatments (5 papers), Plant Molecular Biology Research (3 papers), Dementia and Cognitive Impairment Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). The work is most often cited by research in Neurology (107 citations), Cardiology and Cardiovascular Medicine (289 citations), Cancer Research (176 citations), Endocrinology, Diabetes and Metabolism (194 citations) and Physiology (280 citations). Stacey Melquist has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Judith Bender, Ashley Cannon, Michael Hutton, Linda R. White, Sigrid Botne Sando, Jan Aasly, Stian Lydersen, Ingvild Saltvedt, Olav Sletvold and Peter Clifton. Their work appears in journals such as Circulation, Journal of clinical lipidology, Nature Medicine, Neurology and Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.